Gyre Therapeutics, Inc. Property, Plant and Equipment, Other, Gross
Gyre Therapeutics, Inc. (GYRE) had Property, Plant and Equipment, Other, Gross of $3.38 million as of 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:PropertyPlantAndEquipmentOther · last filed 2012-11-08
- 2012-09-30: Property, Plant and Equipment, Other, Gross $3.38M.
- 2012-06-30: Property, Plant and Equipment, Other, Gross $3.92M.
- 2012-03-31: Property, Plant and Equipment, Other, Gross $4.45M.
- 2011-12-31: Property, Plant and Equipment, Other, Gross $5.04M.
| Period end | Property, Plant and Equipment, Other, Gross |
|---|---|
| 2012-09-30 | $3.38M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $3.92M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $4.45M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $5.04M 10-Q · filed 2012-11-08 |
| 2011-09-30 | $5.41M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $5.86M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $6.07M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |